Embedded Model Predictive Control for a Wearable Artificial Pancreas
- PMID: 33762804
- PMCID: PMC7983018
- DOI: 10.1109/tcst.2019.2939122
Embedded Model Predictive Control for a Wearable Artificial Pancreas
Abstract
While artificial pancreas (AP) systems are expected to improve the quality of life among people with type 1 diabetes mellitus (T1DM), the design of convenient systems that optimize the user experience, especially for those with active lifestyles, such as children and adolescents, still remains an open research question. In this work, we introduce an embeddable design and implementation of model predictive control (MPC) of AP systems for people with T1DM that significantly reduces the weight and on-body footprint of the AP system. The embeddable controller is based on a zone MPC that has been evaluated in multiple clinical studies. The proposed embedded zone MPC features a simpler design of the periodic safe zone in the cost function and the utilization of state-of-the-art alternating minimization algorithms for solving the convex programming problems inherent to MPC with linear models subject to convex constraints. Off-line closed-loop data generated by the FDA-accepted UVA/Padova simulator is used to select an optimization algorithm and corresponding tuning parameters. Through hardware-in-the-loop in silico results on a limited-resource Arduino Zero (Feather M0) platform, we demonstrate the potential of the proposed embedded MPC. In spite of resource limitations, our embedded zone MPC manages to achieve comparable performance of that of the full-version zone MPC implemented in a 64-bit desktop for scenarios with/without meal-disturbance compensations. Metrics for performance comparison included median percent time in the euglycemic ([70, 180] mg/dL range) of 84.3% vs. 83.1% for announced meals, with an equivalence test yielding p = 0.0013 and 66.2% vs. 66.0% for unannounced meals with p = 0.0028.
Keywords: Artificial pancreas; biomedical control; control applications; convex optimization; embedded systems; model predictive control; safety-critical control.
Figures






Similar articles
-
Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75. doi: 10.1177/193229681000400428. J Diabetes Sci Technol. 2010. PMID: 20663463 Free PMC article.
-
Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems.IEEE Trans Biomed Eng. 2018 Mar;65(3):575-586. doi: 10.1109/TBME.2017.2707344. Epub 2017 May 23. IEEE Trans Biomed Eng. 2018. PMID: 28541890 Free PMC article.
-
Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.IEEE Trans Biomed Eng. 2019 Apr;66(4):1045-1054. doi: 10.1109/TBME.2018.2866392. Epub 2018 Aug 21. IEEE Trans Biomed Eng. 2019. PMID: 30142748 Free PMC article.
-
Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes.Front Endocrinol (Lausanne). 2022 Mar 22;12:768639. doi: 10.3389/fendo.2021.768639. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35392357 Free PMC article.
-
Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis.Diabetol Metab Syndr. 2022 Dec 9;14(1):187. doi: 10.1186/s13098-022-00962-2. Diabetol Metab Syndr. 2022. PMID: 36494830 Free PMC article. Review.
Cited by
-
DEMIGOD: A Low-Cost Microcontroller-Based Closed-Loop System Integrating Nanoengineered Sweat-Based Glucose Monitoring and Controlled Transdermal Nanoemulsion Release of Hypoglycemic Treatment with a Software Application for Noninvasive Personalized Diabetes Care.Micromachines (Basel). 2024 Jul 6;15(7):887. doi: 10.3390/mi15070887. Micromachines (Basel). 2024. PMID: 39064398 Free PMC article.
-
Performance Analysis of Different Embedded Systems and Open-Source Optimization Packages Towards an Impulsive MPC Artificial Pancreas.Front Endocrinol (Lausanne). 2021 Apr 26;12:662348. doi: 10.3389/fendo.2021.662348. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33981286 Free PMC article.
-
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.J Diabetes Sci Technol. 2025 Jul;19(4):937-949. doi: 10.1177/19322968251338754. Epub 2025 Jul 1. J Diabetes Sci Technol. 2025. PMID: 40590464 Free PMC article. Review.
References
-
- Zavitsanou S, Chakrabarty A, Dassau E, and Doyle FJ III, “Embedded control in wearable medical devices: application to the artificial pancreas,” Processes, vol. 4, no. 4, p. 35, 2016.
-
- Barnard K, Crabtree V, Adolfsson P, Davies M, Kerr D, Kraus A, Gianferante D, Bevilacqua E, and Serbedzija G, “Impact of type 1 diabetes technology on family members/significant others of people with diabetes,” Journal of diabetes science and technology, vol. 10, no. 4, pp. 824–830, 2016. - PMC - PubMed
-
- Liberman A et al., “Diabetes technology and the human factor,” Diabetes technology & therapeutics, vol. 18, no. S1, pp. S–101, 2016. - PubMed
-
- Kovatchev BP, “Metrics for glycaemic control—from hba 1c to continuous glucose monitoring,” Nature Reviews Endocrinology, vol. 13, no. 7, p. 425, 2017. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources